177 related articles for article (PubMed ID: 35241838)
21. Preservation of the bystander cytocidal effect of irradiated herpes simplex virus thymidine kinase (HSV-tk) modified tumor cells.
Vrionis FD; Wu JK; Qi P; Cano WG; Cherington V
J Neurooncol; 1996 Dec; 30(3):225-36. PubMed ID: 8943097
[TBL] [Abstract][Full Text] [Related]
22. Cooperative therapeutic effects of herpes simplex virus thymidine kinase gene/ganciclovir system and chemotherapeutic agents on prostate cancer in vitro.
Xing Y; Xiao Y; Lu G; Zeng F; Zhao J; Xiong P; Feng W
J Huazhong Univ Sci Technolog Med Sci; 2006; 26(5):610-3. PubMed ID: 17219983
[TBL] [Abstract][Full Text] [Related]
23. Cell-specific targeting of a thymidine kinase/ganciclovir gene therapy system using a recombinant Sindbis virus vector.
Iijima Y; Ohno K; Ikeda H; Sawai K; Levin B; Meruelo D
Int J Cancer; 1999 Jan; 80(1):110-8. PubMed ID: 9935240
[TBL] [Abstract][Full Text] [Related]
24. Selective abolishment of pyrimidine nucleoside kinase activity of herpes simplex virus type 1 thymidine kinase by mutation of alanine-167 to tyrosine.
Degrève B; Esnouf R; De Clercq E; Balzarini J
Mol Pharmacol; 2000 Dec; 58(6):1326-32. PubMed ID: 11093770
[TBL] [Abstract][Full Text] [Related]
25. Prostate cancer gene therapy: herpes simplex virus thymidine kinase gene transduction followed by ganciclovir in mouse and human prostate cancer models.
Eastham JA; Chen SH; Sehgal I; Yang G; Timme TL; Hall SJ; Woo SL; Thompson TC
Hum Gene Ther; 1996 Mar; 7(4):515-23. PubMed ID: 8800746
[TBL] [Abstract][Full Text] [Related]
26. Oxidative stress-regulated lentiviral TK/GCV gene therapy for lung cancer treatment.
Leinonen HM; Ruotsalainen AK; Määttä AM; Laitinen HM; Kuosmanen SM; Kansanen E; Pikkarainen JT; Lappalainen JP; Samaranayake H; Lesch HP; Kaikkonen MU; Ylä-Herttuala S; Levonen AL
Cancer Res; 2012 Dec; 72(23):6227-35. PubMed ID: 23041549
[TBL] [Abstract][Full Text] [Related]
27. Killing effect of the herpes simplex virus thymidine kinase/ganciclovir enzyme/prodrug system on human nasopharyngeal carcinoma cells.
Tang Y; Li J; Zhao S; Liu J
J Int Med Res; 2007; 35(4):433-41. PubMed ID: 17697519
[TBL] [Abstract][Full Text] [Related]
28. Intravenous Administration Is an Effective and Safe Route for Cancer Gene Therapy Using the Bifidobacterium-Mediated Recombinant HSV-1 Thymidine Kinase and Ganciclovir.
Zhou H; He Z; Wang C; Xie T; Liu L; Liu C; Song F; Ma Y
Int J Mol Sci; 2016 Jun; 17(6):. PubMed ID: 27275821
[TBL] [Abstract][Full Text] [Related]
29. Synergistic enhancement of herpes simplex virus thymidine kinase/ganciclovir-mediated cytoxicity by hydroxyurea.
Boucher PD; Ostruszka LJ; Shewach DS
Cancer Res; 2000 Mar; 60(6):1631-6. PubMed ID: 10749133
[TBL] [Abstract][Full Text] [Related]
30. Retrovirus-mediated herpes simplex virus thymidine kinase gene transduction renders human thyroid carcinoma cell lines sensitive to ganciclovir and radiation in vitro and in vivo.
Nishihara E; Nagayama Y; Mawatari F; Tanaka K; Namba H; Niwa M; Yamashita S
Endocrinology; 1997 Nov; 138(11):4577-83. PubMed ID: 9348181
[TBL] [Abstract][Full Text] [Related]
31. A designed equine herpes thymidine kinase (EHV4 TK) variant improves ganciclovir-induced cell-killing.
McSorley T; Ort S; Monnerjahn C; Konrad M
Biochem Pharmacol; 2014 Feb; 87(3):435-44. PubMed ID: 24316433
[TBL] [Abstract][Full Text] [Related]
32. Exogenous wt-p53 enhances the antitumor effect of HSV-TK/GCV on C6 glioma cells.
Huang Q; Pu P; Xia Z; You Y
J Neurooncol; 2007 May; 82(3):239-48. PubMed ID: 17102907
[TBL] [Abstract][Full Text] [Related]
33. Retrovirus-mediated gene therapy of experimental brain neoplasms using the herpes simplex virus-thymidine kinase/ganciclovir paradigm.
Rainov NG; Kramm CM; Aboody-Guterman K; Chase M; Ueki K; Louis DN; Harsh GR; Chiocca A; Breakefield XO
Cancer Gene Ther; 1996; 3(2):99-106. PubMed ID: 8729908
[TBL] [Abstract][Full Text] [Related]
34. STAT3/NF-κB-Regulated Lentiviral TK/GCV Suicide Gene Therapy for Cisplatin-Resistant Triple-Negative Breast Cancer.
Kuo WY; Hwu L; Wu CY; Lee JS; Chang CW; Liu RS
Theranostics; 2017; 7(3):647-663. PubMed ID: 28255357
[TBL] [Abstract][Full Text] [Related]
35. Systemic administration of radiation-potentiated anti-angiogenic gene therapy against primary and metastatic cancer based on transcriptionally controlled HSV-TK.
Hodish I; Tal R; Shaish A; Varda-Bloom N; Greenberger S; Rauchwerger A; Breitbart E; Bangio L; Ben-Shushan D; Pfeffer R; Feder B; Waitsman A; Barshack I; Goldberg I; Mazaki-Tovi S; Peled M; Harats D
Cancer Biol Ther; 2009 Mar; 8(5):424-32. PubMed ID: 19276657
[TBL] [Abstract][Full Text] [Related]
36. Superior cytostatic activity of the ganciclovir elaidic acid ester due to the prolonged intracellular retention of ganciclovir anabolites in herpes simplex virus type 1 thymidine kinase gene-transfected tumor cells.
Balzarini J; Degrève B; Andrei G; Neyts J; Sandvold M; Myhren F; de Clercq E
Gene Ther; 1998 Mar; 5(3):419-26. PubMed ID: 9614564
[TBL] [Abstract][Full Text] [Related]
37. Enhanced therapeutic effect of multiple injections of HSV-TK + GCV gene therapy in combination with ionizing radiation in a mouse mammary tumor model.
Vlachaki MT; Chhikara M; Aguilar L; Zhu X; Chiu KJ; Woo S; Teh BS; Thompson TC; Butler EB; Aguilar-Cordova E
Int J Radiat Oncol Biol Phys; 2001 Nov; 51(4):1008-17. PubMed ID: 11704325
[TBL] [Abstract][Full Text] [Related]
38. Abnormal expression of only the CD34 part of a transgenic CD34/herpes simplex virus-thymidine kinase fusion protein is associated with ganciclovir resistance.
Bennour E; Ferrand C; Rémy-Martin JP; Certoux JM; Gorke S; Qasim W; Gaspar HB; Baumert T; Duperrier A; Deschamps M; Fehse B; Tiberghien P; Robinet E
Hum Gene Ther; 2008 Jul; 19(7):699-709. PubMed ID: 18557699
[TBL] [Abstract][Full Text] [Related]
39. Molecular mechanism for ganciclovir resistance in human T lymphocytes transduced with retroviral vectors carrying the herpes simplex virus thymidine kinase gene.
Garin MI; Garrett E; Tiberghien P; Apperley JF; Chalmers D; Melo JV; Ferrand C
Blood; 2001 Jan; 97(1):122-9. PubMed ID: 11133751
[TBL] [Abstract][Full Text] [Related]
40. [Herpes simplex virus type 1 thymidine kinase/ganciclovir (HSV(1)-TK/GCV) system as an effective "in vivo death switch" of live tumor vaccines].
Kang Y; Xu CJ; Liu XS; Wu CQ; Zhong CP; Gu JR
Ai Zheng; 2005 Aug; 24(8):909-14. PubMed ID: 16086864
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
